Objective To investigate the clinical characteristic and long- term prognosis risk factor of patients with hepatitis B virus- related acute- on- chronic liver failure( HBV- ACLF). Methods The clinical data of 1116 HBV- ACLF patients who were hospitalized in Southwest Hospital of Third Military Medical University from January 2010 to January 2015 were analyzed retrospectively. The risk factors for1- year survival time and prognosis were observed,and the Cox regression model was used to determine the independent risk factors for the prognosis of these patients. The t- test or t'- test was applied for comparison of continuous data between groups,and the chi- square test was applied for comparison of categorical data between groups. Results A total of 562 patients died within the 1- year follow- up period,and the fatality rate was 50. 4%. The comparison between the survival group and the death group showed that age,alanine aminotransferase,total bilirubin,urea nitrogen,serum creatinine,international normalized ratio,serum Na+,white blood cell( WBC),percentage of neutrophils,platelet( PLT),HBV DNA load,Model for End- Stage Liver Disease( MELD) score,ascites,spontaneous bacterial peritonitis,gastrointestinal bleeding,pulmonary infection,sepsis,electrolyte disturbance,hepatic encephalopathy,and acute kidney injury( AKI)were the risk factors for death within 1 year( all P < 0. 05). The Cox regression analysis showed that age,WBC,MELD score,hepatic encephalopathy,electrolyte disturbance,AKI,and PLT were the independent risk factors for the 1- year fatality in HBV- ACLF patients( all P < 0. 05). Conclusion Our findings show that HBV- ACLF has a high fatality rate and is often accompanied by serious complications.The major risk factors affecting the 1- year fatality in HBV- ACLF patients are age,WBC,MELD score,hepatic encephalopathy,electrolyte disturbance,AKI,and PLT.
[1]BROCHARD L,ABROUG F,BRENNER M,et al.An official ATS/ERS/ESICM/SCCM/SRLF statement:prevention and management of acute renal failure in the ICU patient:an international consensus conference in intensive care medicine[J].Am J Respir Crit Care Med,2010,181(10):1128-1155.
|
[2]JALAN R,GINES P,OLSON JC,et al.Acute-on chronic liver failure[J].J Hepatol,2012,57(6):1336-1348.
|
[3]OLSON JC,KAMATH PS.Acute-on-chronic liver failure:concept,natural history,and prognosis[J].Curr Opin Crit Care,2011,17(2):165-169.
|
[4]SARIN SK,KEDARISETTY CK,ABBAS Z,et al.Acute-on-chronic liver failure:consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL)2014[J].Hepatol Int,2014,8(4):453-471.
|
[5]LIU C,WANG YM,FAN K.Epidemiological and clinical features of hepatitis B virus related liver failure in China[J].World J Gastroenterol,2011,17(25):3054-3059.
|
[6]YOU S,RONG Y,ZHU B,et al.Changing etiology of liver failure in 3,916 patients from northern China:a 10-year survey[J].Hepatol Int,2013,7(2):714-720.
|
[7]MOREAU R,JALAN R,GINES P,et al.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J].Gastroenterology,2013,144(7):1426-1437,1437.e1-e9.
|
[8]FU SJ,GAO GS,HU AR,et al.Short-term prognostic value of serum procalctonin and common inflammation markers combined with CTP score in patients with acute-on-chronic liver failure[J].Chin J Pract Intern Med,2015,35(6):519-521.(in Chinese)傅叁君,高国生,胡爱荣,等.血清降钙素原和常用炎症指标联合CTP评分对慢加急性肝衰竭短期预后的预测价值[J].中国实用内科杂志,2015,35(6):519-521.
|
[9] Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association;Severe Liver Diseases and Artificial Liver Group,Chinese Society of Hepatology,Chinese Medical Association.Guidelines for diagnosis and treatment liver failure[J].Chin J Clin Infect Dis,2012,5(6):321-327.(in Chinese)中华医学会感染学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2012年版)[J].中华临床感染病杂志,2012,5(6):321-327.
|
[10]PALEVSKY PM,LIU KD,BROPHY PD,et al.KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury[J].Am J Kidney Dis,2013,61(5):649-672.
|
[11]European Association for the Study of the Liver.EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis[J].J Hepatol,2010,53(3):397-417.
|
[12]MOREAU R,ARROYO V.Acute-on-chronic liver failure:a new clinical entity[J].Clin Gastroenterol Hepatol,2015,13(5):836-841.
|
[13]LIU XY,XIN SJ.Significance of liver failure staging in predicting the prognosis of HBV-acute-on-chronic liver failure[J].Acade J Chin PLA Med Sch,2014,35(6):521-524.(in Chinese)刘晓燕,辛绍杰.肝衰竭分期对HBV感染慢加急性肝衰竭预后判断的意义[J].解放军医学院学报,2014,35(6):521-524.
|
[14]XIA Q,DAI X,ZHANG Y,et al.A modified MELD model for Chinese pre-ACLF and ACLF patients and it reveals poor prognosis in pre-ACLF patients[J].PLoS One,2013,8(6):e64379.
|
[15]SHI Y,ZHENG MH,YANG Y,et al.Increased delayed mortality in patients with acute-on-chronic liver failure who have prior decompensation[J].J Gastroenterol Hepatol,2015,30(4):712-718.
|
[16]MALIK R,MOOKERJEE RP,JALAN R.Infection and inflammation in liver failure:two sides of the same coin[J].J Hepatol,2009,51(3):426-429.
|
[17]CORDOBA J,VENTURA-COTS M,SIMON-TALERO M,et al.Characteristics,risk factors,and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure(ACLF)[J].J Hepatol,2014,60(2):275-281.
|
[18]FICHET J,MERCIER E,GENEE O,et al.Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy[J].J Crit Care,2009,24(3):364-370.
|
[19]SHAWCROSS DL,DAVIES NA,WILLIAMS R,et al.Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis[J].J Hepatol,2004,40(2):247-254.
|
[20]JOSHI D,O'GRADY J,PATEL A,et al.Cerebral oedema is rare in acute-on-chronic liver failure patients presenting with highgrade hepatic encephalopathy[J].Liver Int,2014,34(3):362-366.
|
1. | 吴欢,伍龙,祝娟娟,张权,申晓旭. 不同评分模型对慢加急性肝衰竭患者短期预后的预测价值. 肝脏. 2022(02): 152-159 . ![]() | |
2. | 康玮玮,田辉,冯丽丽,刘立伟,徐曼曼,孔明,段钟平,邹正升,陈煜. 慢加急性肝衰竭患者长期生存状况变化及临床特点分析. 肝脏. 2022(05): 516-520 . ![]() | |
3. | 张天翼,于也萍,夏强,杭化莲. 肝移植治疗慢加急性肝衰竭研究进展. 上海交通大学学报(医学版). 2021(02): 257-261 . ![]() | |
4. | 孙亚男,张世斌,张月宁,李磊,李鹏,武永乐,曾庆环,丁惠国. 食管静脉曲张硬化剂治疗在慢加急性肝衰竭患者中的价值. 临床消化病杂志. 2021(04): 233-237 . ![]() | |
5. | 黄贝贝,宁玲,李文渊,郑晓玮,张玥,江守伟,张振华,李磊. 血浆置换与双重血浆分子吸附系统单用或联合使用治疗HBV 相关慢加急性肝衰竭患者预后预测模型的建立与评估. 临床肝胆病杂志. 2021(12): 2802-2807 . ![]() | |
6. | 胡辉,黄贝贝,宁玲,江守伟,沈强,刘磊,李磊. HBV相关慢加急性肝衰竭患者短期预后预测模型的建立与评价. 临床肝胆病杂志. 2020(01): 123-127 . ![]() | |
7. | 王香梅. 炎症指标在乙肝病毒相关慢加急性肝衰竭并发感染中的诊断价值. 中国当代医药. 2020(32): 86-89 . ![]() | |
8. | 桑培敏,达呼巴雅尔,王乐三,张森茂,叶子薇,刘杰锋,陈斌. 阳黄-阴阳黄-阴黄辨证论治联合西药治疗乙型肝炎相关慢加急性肝衰竭患者生存分析. 中医杂志. 2019(07): 582-586 . ![]() | |
9. | 冯楠,冯波,邢星敏. 红细胞分布宽度、血小板计数与乳酸水平对慢加急性肝衰竭患者经血浆置换治疗预后评估价值. 临床军医杂志. 2019(03): 320-322 . ![]() | |
10. | 余向琼,夏加伟,周鸿雁. 浅析乙型肝炎肝衰竭患者发生肝性脑病的危险因素. 当代医学. 2019(12): 169-170 . ![]() | |
11. | 雷任国. 乙型肝炎慢加急性肝衰竭的治疗新策略与新进展. 中国实用医药. 2019(14): 194-196 . ![]() | |
12. | 肖华莉,王义荣,沈丽霞. 乙型肝炎相关慢加急性肝衰竭患者早期及远期预后的影响因素比较分析. 当代医学. 2019(15): 162-164 . ![]() | |
13. | 邓春荣,姜静,任秀,于代华,范洪伟. ABIC评分对HBV相关慢加急性肝衰竭患者短期生存情况的预测价值. 胃肠病学. 2019(07): 411-415 . ![]() | |
14. | 杨君,黄洋辉. 血清MMP-2, AFP与MELD评分对HBV相关慢加急性肝衰竭患者预后的评估价值. 临床与病理杂志. 2019(08): 1648-1653 . ![]() | |
15. | 韩璞青,孙嫣. 肝衰竭预后评估模型及其在妊娠期肝衰竭中的应用. 临床肝胆病杂志. 2018(03): 635-640 . ![]() | |
16. | 韩璞青,孙嫣. MELD、MELD-Na评分及KCH标准对妊娠期急性肝衰竭患者预后的评估价值. 临床肝胆病杂志. 2018(07): 1508-1513 . ![]() | |
17. | 吴杜娟,金蕾,郜玉峰,叶珺,夏国美,李芳,邹桂舟. 中性粒细胞与淋巴细胞比值对慢加急性肝衰竭患者短期预后的评估价值. 临床肝胆病杂志. 2018(09): 1945-1949 . ![]() | |
18. | 庄焱,谢青. 肝衰竭并发急性肾损伤热点研究新进展. 临床肝胆病杂志. 2018(09): 1836-1841 . ![]() | |
19. | 周洋,王融冰,孟培培. 王融冰教授治疗乙型肝炎病毒相关性慢加急性肝衰竭经验. 中西医结合肝病杂志. 2018(04): 240-241 . ![]() | |
20. | 李晓永,尚华,葛保民,张川,张国顺. HBV感染失代偿期肝硬化并发慢加急性肝衰竭患者的临床特点及预后危险因素分析. 疑难病杂志. 2018(11): 1238-1241 . ![]() | |
21. | 彭景,唐怡. 尿液L-FABP及KIM-1水平用于HBV相关ACLF患者并发AKI的诊断价值. 肝脏. 2018(11): 959-963 . ![]() | |
22. | 沈扬林,李孟英,谭可平,陈婵,陆晖,覃国琦,甘琼萍. 乙型肝炎相关慢加急性肝衰竭患者早期及远期预后的影响因素比较分析. 中国实用医药. 2017(32): 8-10 . ![]() | |
23. | 庞国宏,杨汝磊. 中西医辨证治疗乙型肝炎病毒慢加急性肝衰竭. 吉林中医药. 2017(04): 363-366 . ![]() |